Abstract
Purpose To evaluate changes in monkey optic nerve head (ONH) morphology under acutely controlled intraocular pressure (IOP) and intracranial pressure (ICP).
Methods Seven ONHs from six monkeys were imaged via optical coherence tomography while IOP and ICP were maintained at one of 16 conditions. These conditions were defined by 4 levels for each pressure: low, baseline, high and very high. Images were processed to determine scleral canal area, aspect ratio, and planarity and anterior lamina cribrosa (ALC) shape index and curvature. Linear mixed effect models were utilized to investigate the effects of IOP, ICP and their interactions on ONH morphological features. The IOP-ICP interaction model was compared with one based on translaminar pressure difference (TLPD).
Results We observed complex, eye-specific, non-linear patterns of ONH morphological changes with changes in IOP and ICP. For all ONH morphological features, linear mixed effects models demonstrated significant interactions between IOP and ICP that were unaccounted for by TLPD. Interactions indicate that the effects of IOP and ICP depend on the other pressure. The IOP-ICP interaction model was a higher quality predictor of ONH features than a TLPD model.
Conclusions In vivo modulation of IOP and ICP causes nonlinear and non-monotonic changes in monkey ONH morphology that depend on both pressures and is not accounted for by a simplistic TLPD. These results support and extend prior findings.
Translational Relevance: A better understanding of ICP’s influence on the effects of IOP can help inform the highly variable presentations of glaucoma and effective treatment strategies.
Competing Interest Statement
Proprietary Interest: J.S. Schuman receives royalties for intellectual property licensed by Massachusetts Institute of Technology to Zeiss. All other authors: Nothing to disclose
Footnotes
Proprietary Interest: J.S. Schuman receives royalties for intellectual property licensed by Massachusetts Institute of Technology to Zeiss. All other authors: Nothing to disclose
Financial support: National Institutes of Health grants R01EY025011, R01EY013178, R01EY023966, R01EY022928, R01EY028662, T32-EY017271 and P30EY008098; Glaucoma Research Foundation Shaffer Grant; Eye and Ear Foundation of Pittsburgh, PA; Research to Prevent Blindness (Unrestricted grants to UPMC Ophthalmology and NYU and Stein Innovation Award to Sigal IA).